Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Mehr anzeigen
New patents provide additional composition of matter and methods of use claims for Enveric’s EVM301 series neuroplastogenic molecules, and recently out-licensed tryptamine-derived prodrugs...
Dose-proportional oral bioavailability without clinical signs, including those associated with hallucinogenic compounds, was demonstrated in rat and dog pharmacokinetic (PK) studies while...
Advanced pre-IND activities and research for lead candidate, EB-003, a novel neuroplastogenic molecule designed to treat severe mental health disorders Announced the expansion of patent...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0234 | 7.72277227723 | 0.303 | 0.355 | 0.2955 | 237394 | 0.32552984 | CS |
| 4 | -0.0028 | -0.850546780073 | 0.3292 | 0.3749 | 0.2955 | 140119 | 0.33272421 | CS |
| 12 | -0.0936 | -22.2857142857 | 0.42 | 0.555 | 0.2955 | 580717 | 0.42348278 | CS |
| 26 | -0.2998 | -47.8760779304 | 0.6262 | 0.77 | 0.2955 | 831783 | 0.51644225 | CS |
| 52 | -0.9436 | -74.2992125984 | 1.27 | 2.92 | 0.2955 | 1630796 | 1.1147319 | CS |
| 156 | -0.6136 | -65.2765957447 | 0.94 | 14.87 | 0.1551 | 1367184 | 1.6690857 | CS |
| 260 | -5.6736 | -94.56 | 6 | 14.87 | 0.1551 | 1849335 | 2.46424122 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
